Skip to main content
Health Podcast Library
Episode 39

Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy: Expert Perspectives

Episode Description

In our fourth episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma, our experts discuss one of the most rapidly evolving areas in melanoma care: immunotherapy treatment strategy.

Drawing on decades of combined clinical experience, the panel explores how treatment paradigms are shifting from decisions around monotherapy versus combination immunotherapy, to increasingly nuanced conversations about treatment duration, rechallenge after progression and retreatment following toxicity.

Led by Prof Georgina Long AO, the panel of experts deliver candid expert debate, practical insights and clinical nuance as they explore the evolving landscape of immunotherapy treatment decisions in melanoma care. The panel discusses:     

  • when to stop immunotherapy and why less treatment may sometimes be enough
  • how PET complete metabolic response (CMR) is influencing treatment duration decisions
  • rechallenge strategies after progression or immune-related toxicity
  • managing patients after ipilimumab/nivolumab toxicity
  • the growing move from adjuvant to neoadjuvant treatment approaches.

The discussion also tackles the biology behind durable immune responses, the role of surveillance imaging, and the emerging concept of “definitive immunotherapy”, highlighting how melanoma continues to lead the way in reshaping cancer care.

Be sure to take a look at our earlier episodes from this series.

This special edition vodcast from Melanoma Institute Australia is suitable for Medical Oncologists, Oncology Nurses and other health professionals.

SPEAKERS

  • Prof Georgina Long AO - Medical Oncologist, Melanoma Institute Australia and The University of Sydney
  • Prof Alexander Menzies - Medical Oncologist, Melanoma Institute Australia and The University of Sydney
  • A/Prof Ines Silva - Medical Oncologist, Melanoma Institute Australia
  • A/Prof Matteo Carlino - Medical Oncologist, Melanoma Institute Australia and The University of Sydney

Please note that this presentation was accurate at the time of recording (April 2026) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

This special vodcast is an initiative of ⁠Melanoma Institute Australia⁠ and made possible by an unrestricted educational grant from Bristol Myers Squibb.

For more practise-changing education, visit MIA's ⁠Melanoma Education Portal⁠.

Proudly Supported by

BetterHelpForvis MazarsAAOSCalendarPAmowPod

Patrons of Health Podcast Library

OrthoInfo
AAOS Now Podcast
Achieving Health
AAOS Career Podcast
Aging Like a Pro
Stronger After Stroke
Who the Health Cares? with Prof Michael Sparer

Supporting Shows

HIT Like a Girl Pod: Empowering Women in Health IT
Speak Up For Your Health
Beyond The Paper Gown Podcast
Cuts and Consults
On the Pulse Podcast
Nurse Rosa's INsights
Impulse | Meeting Healthcare Pioneers
Beyond Clinical Walls
Coffee Break: Breaking the Cycle of Bullying in Healthcare, One Cup at a Time
Hopeful Hints
This Just In Radio Show
Faces of Digital Health
HITea With Grace
Healthcare for Humans
Coaching Healthcare Leaders
Thriving with Addiction with Dr. Jonathan Avery

We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies